| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |